# Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)

> **NCT00518245** · PHASE4 · TERMINATED · sponsor: **Canadian Heart Research Centre** · enrollment: 11 (actual)

## Conditions studied

- Unstable Angina

## Interventions

- **DRUG:** enoxaparin

## Key facts

- **NCT ID:** NCT00518245
- **Lead sponsor:** Canadian Heart Research Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-08
- **Primary completion:** 2009-03
- **Final completion:** 2009-08
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Low rate of patient recruitment. Cannot achieve sample size.
- **Last updated:** 2016-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518245, "Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00518245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*